People

Services

Industries

Firm

About

Knowledge

Careers

News

Events

Contact

Connect

Privacy Policy

Disclaimer

Terms of Use

Accessibility

Payments

Legal

Calgary

Toronto

Edmonton

Ottawa

Vancouver

New York

Montréal

Lincoln Caylor

Commercial Litigation and Fraud Lawyer

Partner 

Nathan J. Shaheen

Commercial Disputes and Financial Crimes Lawyer at Bennett Jones Toronto

Partner

Dylan A. Gallant

Commercial Litigation Lawyer at Bennett Jones Toronto

Associate

The federal government recently introduced <a href="https://www.parl.ca/DocumentViewer/en/45-1/bill/C-2/first-reading">Bill C-2</a>, which is known as the Strong Borders Act. It maintains certain proposed amendments to the <a href="https://www.canlii.org/en/ca/laws/stat/sc-2000-c-17/latest/sc-2000-c-17.html">Proceeds of Crime (Money Laundering) and Terrorist Financing Act</a> (the "PCMLTFA") introduced in the prior government's 2024 Fall Economic Statement and proposes various additional amendments.

The Strong Borders Act Seeks to Strengthen the Canadian AML Regime

The Strong Borders Act Seeks to Strengthen the Canadian Anti-Money Laundering Regime

Lincoln Caylor and Nathan J. Shaheen explore the evolving evidentiary threshold for Mareva injunctions in Canada in the Q2 2025 issue of Chambers Digest.

Chancery Lanes Chambers Digest

Mareva Injunctions in Canada: Now Easier to Get?

The recent <a rel="noopener noreferrer" rel="noopener noreferrer" href="https://budget.canada.ca/update-miseajour/2024/report-rapport/FES-EEA-2024-en.pdf" target="_blank">Fall Economic Statement</a> announced the Liberal government’s intention to materially increase the financial (and other) penalties faced by designated individuals and entities doing business in Canada (known as “reporting entities”) that fail to meet the requirements of Canada’s anti-money laundering (AML) regime. While the duration of the Liberal government’s remaining time in power is uncertain, the approach to AML of any Conservative government is unlikely to be less demanding. This is particularly true given the upcoming Mutual Evaluation of Canada by the Financial Action Task Force, which will assess the effectiveness of Canada’s AML regime regardless of the political party in power.

Canada Announces Significantly Increased Penalties for Money Laundering Failures

Lincoln Caylor and Nathan Shaheen authored the Canada chapter of the inaugural <a rel="noopener noreferrer" href="https://www.e-elgar.com/shop/usd/elgar-concise-encyclopedia-of-corruption-law-9781802206487.html" target="_blank">Elgar Concise Encyclopedia of Corruption law</a>. The chapter provides an overview of the core legislative framework governing corruption in Canada and identifies recent developments designed to strengthen anti-corruption measures. It concludes with a discussion of further reform required within Canada’s anti-corruption regime.

The Elgar Concise Encyclopedia on Corruption Law

Serge Dupont

Senior Advisor at Bennett Jones Ottawa

Senior Advisor

Policy and business leaders in 2026 are confronting disruptive global forces that pose daunting economic and financial risks while also transforming markets and creating avenues for growth over the next years.

Economic Outlook Mid Year 2026

A Changing World: New Risks, New Opportunities

2026 Mid-Year Economic Outlook

Alison G. FitzGerald

International Arbitration Lawyer at Bennett Jones Ottawa

Nasra Moumin

Global trade policy is rapidly reshaping the regulatory and commercial landscape for life sciences companies. This update explores how evolving US tariff measures, national security reviews, CUSMA renewal uncertainty and expanding export controls are affecting pharmaceutical and medical device manufacturers operating across borders. The authors also examine Canada&rsquo;s response and the growing compliance, supply chain and market access challenges facing the sector in 2026 and beyond.

The Impact of Global Trade on the Life Sciences Sector

Vincent M. de Grandpré

IP Lawyer | Life Sciences & Tech

Melissa M. Dimilta

Intellectual Property Lawyer at Bennett Jones Toronto

Partner, Trademark Agent

As part of a deeply interconnected global sector, the life sciences industry in Canada is undergoing significant change alongside broad macroeconomic and geopolitical shifts.&nbsp;The Bennett Jones Life Sciences team looks at the top issues and developments affecting the industry in 2026.

2026 Life Sciences outlook

Legal and Market Trends to Watch This Year

Life Sciences Outlook 2026

Emily P. Kettel

Cross-border collaborations are central to the life sciences industry, but they can also raise complex questions about patent infringement liability in Canada. This update examines the Federal Court&rsquo;s recent decision in Adeia Guides Inc v Videotron Ltd and its implications for companies involved in the development, supply and commercialization of patented products and services. The authors explore how Canadian law approaches common design infringement, experimental use exemptions and the potential liability of foreign partners whose activities contribute to products ultimately sold in Canada.

Life Sciences Collaborations and the Risk of Joint Patent Infringement

Aaron E. Sonshine

Corporate Finance, Mergers and Acquisitions and Corporate Governance Lawyer at Bennett Jones Toronto

The life sciences sector is experiencing a renewed wave of M&amp;A activity driven by patent expiries, expanding investor appetite and growing demand for innovative therapies and technologies. Drawing on insights shared at the Bloom Burton &amp; Co. Healthcare Investor Conference, this update explores the key trends shaping dealmaking in Canada and globally, including increased competition for assets, rising private transactions and growing investment in emerging markets such as China. The author also examines why current market conditions point to continued momentum across the sector in the second half of 2026.

Fraud, Asset Tracing and Recovery

From the Same Authors